OpenURL Connection Search

Select item for more details and to access through your institution.

Estimating the half-lives of PCB congeners in former capacitor workers measured over a 28-year interval.
Published in:
Journal of Exposure Science & Environmental Epidemiology, 2011, v. 21, n. 3, p. 234, doi. 10.1038/jes.2010.3
By:
- Seegal, Richard F;
- Fitzgerald, Edward F;
- Hills, Elaine A;
- Wolff, Mary S;
- Haase, Richard F;
- Todd, Andrew C;
- Parsons, Patrick;
- Molho, Eric S;
- Higgins, Donald S;
- Factor, Stewart A;
- Marek, Kenneth L;
- Seibyl, John P;
- Jennings, Danna L;
- Mccaffrey, Robert J
Publication type:
Article
The Phosphodiesterase 10 Positron Emission Tomography Tracer, [<sup>18</sup>F]MNI-659, as a Novel Biomarker for Early Huntington Disease.
Published in:
JAMA Neurology, 2014, v. 71, n. 12, p. 1520, doi. 10.1001/jamaneurol.2014.1954
By:
- Russell, David S.;
- Barret, Olivier;
- Jennings, Danna L.;
- Friedman, Joseph H.;
- Tamagnan, Gilles D.;
- Thomae, David;
- Alagille, David;
- Morley, Thomas J.;
- Papin, Caroline;
- Papapetropoulos, Spyridon;
- Waterhouse, Rikki N.;
- Seibyl, John P.;
- Marek, Kenneth L.
Publication type:
Article
Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects.
Published in:
Journal of Nuclear Medicine, 2012, v. 53, n. 3, p. 378, doi. 10.2967/jnumed.111.090340
By:
- Joshi, Abhinay D.;
- Pontecorvo, Michael J.;
- Clark, Chrisopher M.;
- Carpenter, Alan P.;
- Jennings, Danna L.;
- Sadowsky, Carl H.;
- Adler, Lee P.;
- Kovnat, Karel D.;
- Seibyl, John P.;
- Arora, Anupa;
- Saha, Krishnendu;
- Burns, Jason D.;
- Lowrey, Mark J.;
- Mintun, Mark A.;
- Skovronsky, Daniel M.
Publication type:
Article

Found: 3

Estimating the half-lives of PCB congeners in former capacitor workers measured over a 28-year interval.

The Phosphodiesterase 10 Positron Emission Tomography Tracer, [<sup>18</sup>F]MNI-659, as a Novel Biomarker for Early Huntington Disease.

Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects.